Table 4.
Reported Percentage (%) Utilization of Samples Based on Their Business Plan Status Groups (Responders Only)
| BP+ | BP-IP | BP− | |||||||
|---|---|---|---|---|---|---|---|---|---|
| % Annual utilization rate | N | % | % Cum | N | % | % Cum | N | % | % Cum |
| 0–5 | 21 | 30.4 | 30.4 | 21 | 37.5 | 37.5 | 39 | 46.4 | 46.4 |
| 6–10 | 17 | 24.6 | 55.1 | 12 | 21.4 | 58.9 | 20 | 23.8 | 70.2 |
| 11–20 | 10 | 14.5 | 69.6 | 9 | 16.1 | 75.0 | 14 | 16.7 | 86.9 |
| 21–30 | 6 | 8.7 | 78.3 | 5 | 8.9 | 83.9 | 1 | 1.2 | 88.1 |
| >30 | 15 | 21.7 | 100 | 9 | 16.1 | 100 | 10 | 11.9 | 100 |
Results are presented as the number of biobanks reporting the specific range of % annual utilization rate, the % of biobanks in the group reporting the specific range of % annual utilization rate, and the cumulative percentage (% cum) of biobanks for each group, additive from lowest to highest % annual utilization rate range.